Table 4 Genetic correlation using a leave-one-out analysis approach for hormone-sensitive cancers using bivariate LDSC in the UKB.

From: Considering hormone-sensitive cancers as a single disease in the UK biobank reveals shared aetiology

Cancer types

Women breast cancer

Prostate cancer

Uterine cancer

Colon & rectum

Cancer of kidney

Multiple myeloma

Hormonal cancer (as a single disease)

0.6796 (0.0568)

0.7759 (0.0474)

0.4522 (0.1637)

0.1551 (0.1254)

−0.0786 (0.2362)

0.1129 (0.2056)

Hormonal cancer excluding breast cancer

0.1662 (0.0930)

  

−0.0152 (0.1241)

−0.0088 (0.2290)

0.1926 (0.2295)

Hormonal cancer excluding prostate cancer

 

0.2209 (0.1101)

 

0.3061 (0.1597)

0.0645 (0.2853)

0.0526 (0.2508)

Hormonal cancer excluding ovarian cancer

   

0.1208 (0.1247)

−0.1960 (0.2324)

0.0692 (0.2031)

Hormonal cancer excluding uterine cancer

  

0.3487 (0.1889)

0.1666 (0.1229)

−0.1117 (0.2360)

0.1520 (0.2096)

Hormonal cancer excluding thyroid cancer

   

0.1629 (0.1289)

−0.0561 (0.2386)

0.0605 (0.2108)

  1. Hormone-sensitive cancer type includes five cancers namely women breast cancer, prostate, ovarian, uterine, and thyroid cancer. The genetic correlation involving ovarian and thyroid cancers were not estimable in the LDSC, probably because the numbers of cases for the two cancers were not sufficient (results not shown).